<!DOCTYPE html>
<html>
<head>
    <title>BREAKING: Federal Register: Clinical Trial Considerations To Support Accelerated Approval of Oncology Therapeutics; Draft Guidance for Industry; Availability</title>
    <meta charset="UTF-8">
    <style>
        body { font-family: Georgia, serif; max-width: 800px; margin: 0 auto; padding: 20px; }
        h1 { border-bottom: 2px solid #333; }
        .breaking { background: #fff3cd; border-left: 4px solid #dc3545; padding: 15px; }
        .source { background: #f8f9fa; padding: 10px; margin-top: 20px; font-size: 0.9em; }
        .timestamp { color: #666; }
    </style>
</head>
<body>
    <h1>BREAKING: Federal Register: Clinical Trial Considerations To Support Accelerated Approval of Oncology Therapeutics; Draft Guidance for Industry; Availability</h1>
    <p class="timestamp">Published: 2023-03-27 | Source: Federal Register</p>
    <div class="breaking">
        <p><strong>The Food and Drug Administration (FDA or Agency) is announcing the availability of a draft guidance for industry entitled "Clinical Trial Considerations to Support Accelerated Approval of Oncology Therapeutics." The purpose of this guidance is to provide recommendations to sponsors of anti-cancer drugs or biological products on considerations for designing trials intended to support accelerated approval. The accelerated approval pathway is commonly used for approval of oncology drugs due to the ...</strong></p>
    </div>
    <h2>Document Details</h2>
    <p><strong>Document Type:</strong> Notice</p>
    <p><strong>Agency:</strong> Health and Human Services Department, Food and Drug Administration</p>
    <p><strong>Document Number:</strong> 2023-05910</p>
    <p><strong>Publication Date:</strong> 2023-03-27</p>
    <h2>Official Source</h2>
    <p>Read the full document at: <a href="https://www.federalregister.gov/documents/2023/03/27/2023-05910/clinical-trial-considerations-to-support-accelerated-approval-of-oncology-therapeutics-draft">https://www.federalregister.gov/documents/2023/03/27/2023-05910/clinical-trial-considerations-to-support-accelerated-approval-of-oncology-therapeutics-draft</a></p>
    <div class="source"><strong>Source:</strong> Federal Register - 2023-05910</div>
    <p><a href="index.html">Back to Breaking News Wire</a></p>
</body>
</html>
